Erratum to: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.

After the publication of this article it has been brought to our attention that the data in Table 3 (Table 1 in this Erratum) and in the Additional file 3: Table S3 (Additional File 1 in this Erratum) contained mistakes as detailed below. These mistakes have been corrected in this Erratum.

Table 3

Administrative and clinical outcomes by fluid cohort

Outcome/Complication	Saline (n = 1558) % (n)	Balanced (n = 1558) % (n)	Unadjusted odds ratio (95 % CI)	Adjusted odds ratio (95 % CI)
Administrative Outcomes
Cardiac	8.66 (135)	4.43 (69)	0.488 (0.362–0.659)	0.387 (0.276–0.544)
Hemorrhage	0.71 (11)	0.51 (8)	0.726 (0.291–1.809)	0.681 (0.264–1.757)
Infectious	10.14 (158)	6.03 (94)	0.569 (0.436–0.742)	0.526 (0.396–0.699)
Gastrointestinal	5.46 (85)	5.13 (80)	0.938 (0.685–1.284)	0.881 (0.636–1.220)
Neurologic	1.16 (18)	0.83 (13)	0.72 (0.352–1.474)	0.585 (0.275–1.245)
Acute renal failure	4.36 (68)	3.34 (52)	0.757 (0.524–1.093)	0.676 (0.447–1.023)
Respiratory failure	5.46 (85)	3.47 (54)	0.622 (0.439–0.882)	0.624 (0.429–0.908)
New organ failure	9.11 (142)	7.12 (111)	0.765 (0.59–0.991)	0.707 (0.506–0.986)
Clinical Outcomes
Hospital mortality	3.27 (51)	1.03 (16)	0.307 (0.174–0.54)	0.373 (0.204–0.681)
30–day readmissions	9.5 (148)	7.64 (119)	0.788 (0.612–1.014)	0.801 (0.618–1.036)
60–day readmissions	13.54 (211)	10.91 (170)	0.782 (0.63–0.97)	0.804 (0.645–1.004)
90–day readmissions	16.56 (258)	12.58 (196)	0.725 (0.593–0.886)	0.735 (0.598–0.904)
Cardiac
Dysrhythmia	10.65 (166)	6.87 (107)	0.618 (0.48–0.797)	0.632 (0.485–0.823)
Cardiac stress	6.42 (100)	2.05 (32)	0.306 (0.204–0.458)	0.289 (0.188–0.483)
Heart failure	4.04 (63)	1.48 (23)	0.356 (0.219–0.576)	0.447 (0.268–0.747)
Hemorrhage/Hematologic
Coagulopathya	11.09 (150)	7.71 (106)	0.67 (0.516–0.87)	0.602 (0.450–0.806)
Received blood transfusion	2.92 (46)	2.27 (36)	0.777 (0.5–1.209)	0.629 (0.389–1.018)
Bleeding	20.09 (313)	19.96 (311)	0.992 (0.832–1.182)	1.134 (0.942–1.365)
Infectious
Pneumonia	6.03 (94)	2.12 (33)	0.337 (0.225–0.504)	0.349 (0.226–0.539)
Sepsis	10.53 (164)	5.65 (88)	0.509 (0.389–0.666)	0.534 (0.401–0.711)
Urinary tract infection	5.91 (92)	4.69 (73)	0.783 (0.571–1.074)	0.884 (0.632–1.237)
Line infection	0.77 (12)	0	–	–
Gastrointestinal
Cholecystitis	4.75 (74)	3.53 (55)	0.734 (0.514–1.048)	0.753 (0.517–1.098)
Renal
Acute Kidney Injury	5.46 (85)	4.43 (69)	0.803 (0.580–1.112)	1.052 (0.760–1.455)
Electrolyte Abnormalities
Low magnesium with replacement	4.36 (68)	2.12 (33)	0.474 (0.311–0.723)	0.565 (0.362–0.880)
High magnesium	4.43 (69)	3.4 (53)	0.760 (0.528–1.095)	0.822 (0.553–1.221)
Low potassium with replacement	14.12 (220)	7.51 (117)	0.494 (0.39–0.625)	0.510 (0.393–0.660)
High potassium	9.44 (147)	6.87 (107)	0.708 (0.546–0.918)	0.848 (0.643–1.118)
Low sodium	39.41 (614)	30.62 (477)	0.678 (0.585–0.787)	0.703 (0.602–0.821)
High sodium	7 (109)	6.03 (94)	0.854 (0.642–1.135)	0.965 (0.710–1.311)
Low calcium with replacement	1.16 (18)	0.77 (12)	0.664 (0.319–1.383)	1.125 (0.534–2.369)
Metabolic Acidosis
Lactic (pH and lactate)	0.71 (11)	0.26 (4)	0.362 (0.115–1.139)	0.397 (0.106–1.487)
Metabolic (pH and bicarbonate)	2.76 (43)	1.22 (19)	0.435 (0.252–0.75)	0.749 (0.399–1.403)
Hyperchloremic (pH and chloride)	3.47 (54)	1.22 (19)	0.344 (0.203–0.583)	0.477 (0.262–0.868)

aExcluded patients receiving warfarin

The following values have been corrected in Table 3 (Table 1 in this Erratum):

the entire column (far right) "Adjusted Odds Ratio (95 % CI)"

under Electrolyte Abnormalities, the value for "High Mg" within the column "Saline n (%)" and the values for "Unadjusted Odds Raio (95 % CI)" and "Adjusted Odds Ratio (95 % CI)"

under Electrolyte Abnormalities, ALL values for the row labelled "Low Ca with replacement"

The single value for SOFA CV Level 2 "Saline cohort n (%)" in Table S3 (Additional File 1 in this Erratum) has been corrected.

In addition, we noticed that the legend for Fig. 2 (Fig. 1 in this Erratum) was incorrectly given as “Administrative and clinical outcomes unadjusted and adjusted for Acute Physiology Score”. The correct legend for Fig. 2 is “Administrative and clinical outcomes unadjusted and adjusted for APS, Elixhauser comorbidities of congestive heart failure, hypertension and lymphoma, admission source, census region, and payer.” The labels above the right-hand side plots within the figure also needed corrections and have been updated in this erratum.

Fig. 2

legend, edit to: Administrative and clinical outcomes unadjusted and adjusted for APS, Elixhauser comorbidities of congestive heart failure, hypertension and lymphoma, admission source, census region, and payer